AVITA Medical (RCEL) files $200M S-3 shelf to sell stock, warrants

robot
Abstract generation in progress

AVITA Medical, Inc. (RCEL) has filed an S-3 shelf registration statement to offer up to $200 million in common stock, preferred stock, warrants, and units. The company intends to use the net proceeds for general corporate purposes, including capital expenditures and working capital. Specific terms of each offering, such as pricing and distribution methods, will be detailed in future prospectus supplements.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin